Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome.
about
Real-world study of everolimus in advanced progressive neuroendocrine tumors.Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).The underestimated role of somatostatin analogs in the NETTER-1 trial.Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis.Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis.Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour.[Grading of neuroendocrine tumors].Impact of everolimus on Japanese patients with advanced pancreatic neuroendocrine neoplasms.
P2860
Q33417013-03F6F855-FDB5-474D-B9DC-99A2429D1AB3Q36344419-C7DA5FC1-5FE5-4B06-905D-2615A28230B0Q36849357-0E22008C-E323-4F45-86AA-84B915C633E3Q38264620-DCA85487-DC21-4482-BD3D-4DC672E1530DQ38685351-CCF8CF06-26B9-4C85-A368-3ECE87BA4910Q38844841-32ED3920-CDBE-4FF1-9C23-944A61CDDBA6Q39237792-50F6157E-CA8F-45C2-B4E9-E6862F9B2FF3Q50038850-4CC41F47-5984-41CE-A05B-52259BD5FFFAQ52841424-AAF33BEE-E4B5-4D0E-9807-B376288C31AEQ53037246-4592C343-AC17-432E-8C95-4206754EC47FQ53073082-2E529150-2051-4892-951C-ACC1C9018B50Q53545250-E769BD0C-18D1-4CA0-BC12-89C081C752D6
P2860
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Advanced digestive neuroendocr ...... or affecting clinical outcome.
@en
Advanced digestive neuroendocr ...... or affecting clinical outcome.
@nl
type
label
Advanced digestive neuroendocr ...... or affecting clinical outcome.
@en
Advanced digestive neuroendocr ...... or affecting clinical outcome.
@nl
prefLabel
Advanced digestive neuroendocr ...... or affecting clinical outcome.
@en
Advanced digestive neuroendocr ...... or affecting clinical outcome.
@nl
P2093
P50
P1433
P1476
Advanced digestive neuroendocr ...... tor affecting clinical outcome
@en
P2093
Elettra Merola
Elsa Iannicelli
Emanuela Pilozzi
Gianfranco Delle Fave
Maria Rinzivillo
Paola Tomassetti
Paolo Mercantini
P304
P356
10.1097/MPA.0000000000000032
P50
P577
2014-03-01T00:00:00Z